Results 21 to 30 of about 171,497 (229)

Rationale and study design of intravenous loop diuretic administration in acute heart failure. DIUR-AHF [PDF]

open access: yes, 2017
Aims: Although loop diuretics are the most commonly used drugs in acute heart failure (AHF) treatment, their short-term and long-term effects are relatively unknown.
Di Somma, Salvatore   +5 more
core   +1 more source

Diuretics in modern nephrology

open access: yesPočki, 2019
The paper considers the problem of using loop diuretics in patients with chronic kidney disease associated with cardiovascular risk, such as heart failure, hypertension, edema syndrome, including those against diabetes mellitus. Three therapeutic margins
D.D. Ivanov
doaj   +1 more source

Atypical presentation of rhabdomyolysis due to hypokalaemia induced by diuretics abuse: Case report from Sierra Leone.

open access: yesRevista de la Facultad de Ciencias Médicas de Córdoba, 2018
Rhabdomyolysis results from acute necrosis of skeletal muscle fibres and consequent leakage of muscle constituents into the circulation. Its association with anything different than trauma in the Emergency Room is not that frequent.
Fernando Daniel Berdaguer Ferrari   +5 more
doaj   +1 more source

Long-term outcome after tricuspid valvectomy in a neonate with Candida endocarditis : a case report [PDF]

open access: yes, 2019
Tricuspid valvectomy is a rare surgical intervention, and knowledge regarding long-term outcome in children is lacking. We report a favourable outcome 11 years after tricuspid valvectomy in early infancy without subsequent surgery or other cardiac ...
Bogers, Ad JJC   +2 more
core   +1 more source

Clinical Pharmacology & Therapeutic uses of Diuretic Agents: A Review [PDF]

open access: yes, 2022
The osmolarity of both blood and urine will increase if the kidneys are unable to eliminate excess water and electrolytes. NPS can be treated by restricting salt intake and using diuretics. Loop diuretics.
Agnihotri, Nidhee   +8 more
core   +2 more sources

Outcomes Associated With a Strategy of Adjuvant Metolazone or High‐Dose Loop Diuretics in Acute Decompensated Heart Failure: A Propensity Analysis

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018
Background In acute decompensated heart failure, guidelines recommend increasing loop diuretic dose or adding a thiazide diuretic when diuresis is inadequate.
Meredith A. Brisco‐Bacik   +7 more
doaj   +1 more source

Why do SGLT2 inhibitors reduce heart failure hospitalization? A differential volume regulation hypothesis [PDF]

open access: yes, 2017
The effect of a sodium glucose cotransporter 2 inhibitor (SGLT2i) in reducing heart failure hospitalization in the EMPA-REG OUTCOMES trial has raised the possibility of using these agents to treat established heart failure.
De Vecchis   +22 more
core   +1 more source

One‐Year Mortality After Intensification of Outpatient Diuretic Therapy

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020
Background Mortality is increased following a hospitalization for decompensated heart failure (HF), during which diuretics are usually intensified. It is unclear how risk is affected after outpatient intensification of diuretic therapy for HF.
Christian Madelaire   +11 more
doaj   +1 more source

Looking inside the black box : a theory-based process evaluation alongside a randomised controlled trial of printed educational materials (the Ontario printed educational message, OPEM) to improve referral and prescribing practices in primary care in Ontario, Canada [PDF]

open access: yes, 2007
Background: Randomised controlled trials of implementation strategies tell us whether (or not) an intervention results in changes in professional behaviour but little about the causal mechanisms that produce any change.
CL Gilliss   +33 more
core   +6 more sources

PREMENSTRUAL SYNDROME NEW POSSIBILITIES OF THERAPY

open access: yesМедицинский совет, 2017
The premenstrual syndrome (PMS) is a complex pathological symptom manifesting itselft through variety of neuropsychiatric, vegetative-vascular and metabolic-endocrine disorders that affect the quality of life of patients and reduces their working ability.
O. I. Lisitsyna, E. G. Khilkevich
doaj   +1 more source

Home - About - Disclaimer - Privacy